Mirae Asset Global Investments Co., Ltd.

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1569395 SEOUL, M5

Position in FULC

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$10,906

-$15,739 QoQ

Shares Held

2,980

-14.2% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#125

of 155 holders

Holding Since

Sep 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Mirae Asset Global Investments Co., Ltd. holds $279,047,947 across 206 Biotechnology names. FULC ranks #184 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	210,209	$104,417,115
2	REGN	Regeneron Pharmaceuticals, Inc.	93,632	$58,383,296
3	ALNY	Alnylam Pharmaceuticals, Inc.	61,531	$18,522,675
4	MDGL	Madrigal Pharmaceuticals, Inc.	33,420	$17,944,868
5	ARGX	Argenx SE	11,164	$10,357,623
6	ONC	BeOne Medicines Ltd.	33,808	$9,634,265
7	RPRX	Royalty Pharma plc	150,556	$8,441,674
8	INCY	Incyte Corp	63,812	$7,233,728

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,906	2,980	-14.2%	Shares	Sole	2026-07-22
2026-03-31	$26,645	3,474	+32.1%	Shares	Sole	2026-05-04
2025-12-31	$29,745	2,630	+16.5%	Shares	Sole	2026-01-26
2024-09-30	$8,057	2,257	+21.6%	Shares	Sole	2024-10-23
2024-06-30	$11,507	1,856	-94.3%	Shares	Sole	2024-07-30
2024-03-31	$307,658	32,591	+1.0%	Shares	Defined	2024-05-01
2023-03-31	$91,980	32,274	+137.8%	Shares	Defined	2023-05-04
2022-12-31	$98,788	13,570	+0.1%	Shares	Defined	2023-02-09
2022-09-30	$109,634	13,552	—	Shares	Defined	2022-11-10
No filing history on record for this holder in this stock.